EUVIMEDEUVIMED entdecken
Open Access

Urine Tenofovir Levels Strongly Correlate With Virologic Suppression in Patients With Human Immunodeficiency Virus on Tenofovir Alafenamide-Based Antiretroviral Therapy

Kelly A Johnson iD, Hideaki Okochi, Mireya Arreguin, Joseph Watabe, David V Glidden, Anindita Chattopadhyay, Elizabeth Imbert, Matthew D Hickey, Monica Gandhi, Matthew Spinelli

Clinical Infectious Diseases · 04.03.2023 · 76 (5) · 930-933

DOI: 10.1093/cid/ciac828 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 18.10.2022. Verfasst von Kelly A Johnson und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of California San Francisco, San Francisco, California, USA. Hauptthemen laut MEDLINE: Anti-HIV Agents, HIV-1, HIV Infections. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, NIAID NIH HHS, National Institute of Mental Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We found that urine tenofovir (TFV) levels >1500 ng/mL strongly predict virologic suppression among people with human immunodeficiency virus taking tenofovir alafenamide (odds ratio, 5.66; 95% confidence interval, 1.59–20.14; P = .007). This suggests an existing point-of-care assay developed for tenofovir disoproxil fumarate will support adherence monitoring for patients on all TFV-based antiretrovirals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-HIV AgentsHIV-1HIV InfectionsHumansTenofovirAlanineAdenine

Stichwörter der Autor:innen

adherencepoint-of-care monitoringtenofovir alafenamideviral suppression

Substanzen

TenofovirAnti-HIV AgentsAlanineAdenine

Autor:innen und Institutionen

  • Department of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Department of Epidemiology & Biostatistics, University of California San Francisco, San Francisco, California, USA.

ORCID-Profile: Kelly A Johnson

Förderung

  • NIMH NIH HHS
  • NIAID NIH HHS
  • National Institute of Mental Health
  • National Institute of Allergy and Infectious Diseases
  • National Institutes of Health

Zitieren

APA

Johnson, K. A., Okochi, H., Arreguin, M., Watabe, J., Glidden, D. V., Chattopadhyay, A., Imbert, E., Hickey, M. D., Gandhi, M., & Spinelli, M. (2023). Urine Tenofovir Levels Strongly Correlate With Virologic Suppression in Patients With Human Immunodeficiency Virus on Tenofovir Alafenamide-Based Antiretroviral Therapy. Clinical Infectious Diseases, 76(5), 930-933. https://doi.org/10.1093/cid/ciac828

Vancouver

Johnson KA, Okochi H, Arreguin M, Watabe J, Glidden DV, Chattopadhyay A, et al. Urine Tenofovir Levels Strongly Correlate With Virologic Suppression in Patients With Human Immunodeficiency Virus on Tenofovir Alafenamide-Based Antiretroviral Therapy. Clinical Infectious Diseases. 2023;76(5):930-933. doi:10.1093/cid/ciac828

BibTeX
@article{Johnson2023,
  author = {Johnson, Kelly A and Okochi, Hideaki and Arreguin, Mireya and Watabe, Joseph and Glidden, David V and Chattopadhyay, Anindita and Imbert, Elizabeth and Hickey, Matthew D and Gandhi, Monica and Spinelli, Matthew},
  title = {Urine Tenofovir Levels Strongly Correlate With Virologic Suppression in Patients With Human Immunodeficiency Virus on Tenofovir Alafenamide-Based Antiretroviral Therapy},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  volume = {76},
  number = {5},
  pages = {930--933},
  doi = {10.1093/cid/ciac828}
}
Kostenlos starten →